Is there a sex bias in prescribing anti-tumour necrosis factor medications to patients with rheumatoid arthritis? A nation-wide cross-sectional study

Annals of the Rheumatic Diseases

Volumn 71, Issue 7, 2012, Pages 1203-1206

  Arkema, Elizabeth V ^a   Neovius, Martin ^a   Joelsson, Joel K ^b   Simard, Julia F ^a   Van Vollenhoven, Ronald F ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE REGISTRY; ERYTHROCYTE SEDIMENTATION RATE; ETHNIC GROUP; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SWEDISH;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYPERALGESIA; IMMUNOGLOBULIN G; JOINTS; MALE; MIDDLE AGED; PREJUDICE; RECEPTORS, TUMOR NECROSIS FACTOR; REGISTRIES; SWEDEN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862516775     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200947     Document Type: Article

References (19)

1. Neovius M, Simard JF, Askling J. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis 2011; 70:624-9.
2. Forslind K, Hafström I, Ahlmén M, et al. Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 2007;66:46-52.
3. Tengstrand B, Ahlmén M, Hafström I. The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years. J Rheumatol 2004;31:214-22. (Pubitemid 38160740)
4. Kuiper S, van Gestel AM, Swinkels HL, et al . Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J Rheumatol 2001; 28:1809-16. (Pubitemid 32726927)
5. Symmons DP. Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol 2002;16:707-22.
6. Da Silva JA, Hall GM. The effects of gender and sex hormones on outcome in rheumatoid arthritis. Baillieres Clin Rheumatol 1992;6:196-219.
7. Cutolo M, Villaggio B, Seriolo B, et al. Synovial fluid estrogens in rheumatoid arthritis. Autoimmun Rev 2004;3:193-8. (Pubitemid 38521094)
8. Wilder RL. Hormones, pregnancy, and autoimmune diseases. Ann N Y Acad Sci 1998;840:45-50. (Pubitemid 28302034)
9. Da Silva JA, Spector TD. The role of pregnancy in the course and aetiology of rheumatoid arthritis. Clin Rheumatol 1992;11:189-94.
10. Brennan P, Silman A. Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum 1994;37:808-13. (Pubitemid 24184529)
11. Fransen J, van Riel PL. The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 2005;23:S93-9. (Pubitemid 46657516)
12. Sokka T, Toloza S, Cutolo M, et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 2009;11:R7.
13. Leeb BF, Haindl PM, Maktari A, et al. Disease activity score-28 values differ considerably depending on patient's pain perception and sex. J Rheumatol 2007;34:2382-7. (Pubitemid 350230659)
14. Neovius M, Simard J, Sundström A, et al. Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register. Ann Rheum Dis 2011;70:516-9.
15. Simard JF, Arkema EV, Sundström A, et al. Ten years with biologics: to whom do data on effectiveness and safety apply? Rheumatology (Oxford) 2011;50:204-13.
16. Prevoo ML, van 't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
17. Kristensen LE, Kapetanovic MC, Gülfe A, et al. Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register. Rheumatology (Oxford) 2008;47:495-9.
18. Unruh AM. Gender variations in clinical pain experience. Pain 1996;65:123-67. (Pubitemid 26228032)
19. Bingefors K, Isacson D. Epidemiology, co-morbidity, and impact on health-related quality of life of self-reported headache and musculoskeletal pain-a gender perspective. Eur J Pain 2004;8:435-50. (Pubitemid 39485768)